Cerebrolysine

Cerebrolysin: Positive Cognitive Effect in Vascular Dementia

Pauline Anderson

Feb 05, 2013

 

• Cerebrolysin Trial in Stroke Fails to Meet Primary Endpoint But Shows Positives
• Alzheimer's Disease News & Perspectives
• Stroke/Cerebrovascular Disease News & Perspectives

Drug & Reference Information

• Vascular Dementia
• Neurological Manifestations of Vascular Dementia
• Carotid Artery Stenosis Imaging

Cerebrolysin, a peptide preparation produced from purified pig brain proteins, may have positive effects on cognitive function in older patients with vascular dementia (VaD), according to a new meta-analysis.

The analysis also found that most adverse effects related to Cerebrolysin were mild to moderate in severity.

"However, due to the limited number of included trials, varying treatment durations, and short-term follow-up, there is insufficient evidence to recommend Cerebrolysin as a routine treatment for patients with VaD," write the authors, led by Ning Chen, Department of Neurology, West China Hospital, Sichuan University, Chengdu, China./.../

Brain Cortex

Alzheimer’s Signs May Show Up 10 Years Before Doctors Realize

Rachael Rettner, MyHealthNewsDaily

Happy older woman. CREDIT: stock.xchng

Brains may start showing signs of Alzheimer's disease about a decade before the condition is recognized by doctors, a new study suggests.

Brain scans showing shrinkage in the cerebral cortex of seniors who later developed dementia suggested that researchers had found a marker for Alzheimer's.

Measurements of those areas "could be very important indicators to help identify who may be at risk of developing Alzheimer's dementia," study researcher Leyla deToledo-Morrell, said in a news release. "If a drug therapy or treatment is developed in the future, those who are still without symptoms but at great risk would benefit the most from treatment." DeToledo-Morrell is a professor in the department of neurological sciences at Rush University Medical Center in Chicago./.../